Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Novo Nordisk continues to make headway in the development of Degludec and DegludecPlus, the company’s two new “next-generation” insulins. The company recently announced...
Former ADA President Dr. John Buse offers a take on the ADA and FDA and weighs in on the current regulatory environment and healthcare reform.
Obesity expert Dr. Lee Kaplan of Massachusetts General Hospital tells us how we may be able to bypass the bypass…
We recently reviewed three drug candidates for the treatment of obesity – Contrave, lorcaserin, and Qnexa. All three drugs in development: they all have been submitted...
A girl can dream, right? (...of cures and new insulins...)
A thorough review and “how-to” on the drug Symlin (Amylin’s pramlintide).
Juvenile Diabetes Research Foundation President and CEO Dr. Alan Lewis discusses the organization's priorities, one year in.
Learn about anti-CD3 therapy designed to slow or stop the progression of type 1 diabetes.